Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... contracts from the Department of Defense for development of a therapeutic vaccine for Hepatitis C, and from the National Institute of Allergy and Infectious Diseases (via the ...
2009 NOV 2 ... virus. "The confirmation of the same Hemopurifier=AE we are advancing in Hepatitis-C (HCV) care, having significant activity against H1N1 virus is quite timely when ... therapeutic option against emerging strains of influenza that are resistant to drug and vaccine therapies. Keywords: Gastroenterology, HCV, Hepatitis C Virus, Hepatology, ...
2009 NOV 2 ... study discovered brain damage in newborn monkeys who were given a mercury-containing Hepatitis B vaccine," says Scott Laster of SafeMinds. The protest starts at 7:30am ...
2009 NOV 16 ... tumour type and may also be of potential utility in the development of vaccines against hepatitis, HIV and other chronic infectious diseases. Keywords: AIDS, Acquired ... therapeutic cancer vaccines based on its patented ImmunoBody® platform, SCIB1 DNA vaccine has been successfully completed ahead of the planned clinical trials that are expected ...
2009 NOV 9 ... published in the Journal of General Virology, "Understanding the origin and nature of hepatitis C virus (HCV) genetic diversity is critical for improving treatment and vaccine design, ...
2009 NOV 16 ... will provide valuable perspective as Dynavax advances its plans for its Phase 3 hepatitis B vaccine and pipeline products." Dr. Cano is President and Founder of ...
2009 NOV 9 ... (Nasdaq: DVAX) announced the first clinical data for HEPLISAVTM investigational hepatitis B vaccine in chronic kidney disease patients. These data will be presented in a poster ...
2009 NOV 16 ... of drug candidates targeted to Toll-like receptors for potential applications in chronic hepatitis C virus infection and autoimmune diseases, and to support our partnered programs in ... diseases, and to support our partnered programs in oncology, respiratory disease, and vaccine adjuvants," said Sudhir Agrawal, D. Phil., President, Chief Executive Officer and Chief ...
2009 NOV 23 ... to develop novel adjuvants to support the development of an effective vaccine against hepatitis C virus." Dr. Gale's laboratory has been instrumental in defining the ...
2009 NOV 2 ... "Hepatitis C virus (HCV) infection, clearance, and reinfection are best studied in injection drug ... The researchers concluded: "These results should inform HCV clinical care and vaccine development." Page and colleagues published their study in the Journal of ...
2009 NOV 2 ... viruses from activated sludge. Test samples were inoculated with human adenovirus (AdV), hepatitis A virus (HAV), poliovirus (PV) and rotavirus (RV) and were then processed by an ... Virology, HAV, Hepatology, Gastroenterology, Infectious Disease, Adenoviridae, Polio Vaccine, Polio Immunization, Vaccination, Rotavirus Vaccine, Viral, Federal University. ...
2009 NOV 23 ... repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. To receive future updates, via email including quarterly ... US$41 billion international healthcare company, is acquiring an 85% stake in HTDS' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd., for US$125 million. Novartis of ...
2009 NOV 2 ... "In recent years, the number of travelers aged >40 years who acquire hepatitis A while traveling has increased. Therefore, there is a need to review hepatitis A ... and 97.5% (95% CI: 87.4-99.6), respectively. The CVP was 58.4% using two doses of vaccine. The CVP was lower than the prevalence rate found in our international travelers," ...
2009 NOV 16 ... According to a study from Perth, Australia, "Many hepatitis C virus (HCV) infections worldwide are with the genotype I and 3 strains of the virus. ... have implications for future therapeutic strategies to combat HCV infection, including vaccine design. (HEPATOLOGY 2009;50:1017-1029.)." Rauch and colleagues published ...
2009 NOV 23 ... Data detailed in 'Towards a small animal model for hepatitis C' have been presented. "Hepatitis C virus (HCV) causes chronic liver disease and ... Options for the prevention or therapy of HCV infection are limited; there is no vaccine and the nonspecific, interferon-based treatments now in use are frequently ineffective ...
2009 NOV 16 ... the measles-mumps-rubella vaccine (MMRV), pneumococcal conjugate vaccine (PCV7), and a Hepatitis A (HepA) vaccine at 12 months of age. In the control group, 12-month-olds received only ...
2009 NOV 2 ... a previous STI. Twenty-one men had syphilis and a further six tested positive for HIV. Hepatitis B vaccination was completed for 41% of the clients seen. Those who tested positive for ... Virus Bacterial Infection, Virology. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 NOV 23 ... According to a study from Taipei, Taiwan, "Hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma. This ... whether prevention of hepatocellular carcinoma by the universal Taiwanese HBV vaccine program, launched in July 1984, has extended beyond childhood and to identify the ...
2009 NOV 23 ... to a study from Havana, Cuba, "CIGB-230, a mixture of a DNA plasmid expressing hepatitis C virus (HCV) structural antigens and a HCV recombinant capsid protein, has demonstrated ... after the administration of CIGB-230 in mice, as well as toxicity of this vaccine candidate in rats." "In the biodistribution study, mice received single ...
2009 NOV 9 ... other vaccines recommended to be given at an earlier age: measles- mumps-rubella (MMR), hepatitis B and varicella (chickenpox) vaccine. Influenza vaccine is also recommended every year ...
